&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2024-04-04, 19:11
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-15, 04:41
Kura Oncology Announces Acceptance of Two Abstracts for
– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine kinase inhibitors – SAN DIEGO, March ...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-16, 19:46
Kura Oncology to Report Fourth Quarter and Full Year 2022
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the...
